Jean-Charles Soria selected to the American Association for Cancer Research Board of Directors
Jean-Charles Soria, SVP and Oncology Therapeutic Area Head at
“Thank you to my American Association for Cancer Research colleagues for this humbling vote of confidence.
I’ve been an active member of the AACR throughout my career and look forward to deepening my involvement within the organization. Alongside respected peers from across the globe, I hope to expand and accelerate deep scientific translational research and further the AACR’s legacy as the leading cancer research organization.
Congratulations to the other newly elected Board members, Electra Paskett, Manuel Hidalgo Medina, MD, PhD, Katerina Politi and Catherine Wu! I look forward to working together over our three-year term. ”
Quoting Amgen Oncology’s post:
“Congratulations to Jean-Charles Soria, MD, PhD, Amgen’s SVP and Oncology Therapeutic Area Head, on his election to the American Association for Cancer Research (AACR) Board of Directors.
For the next three years, Jean-Charles will lend his expertise in precision medicine and immuno-oncology to help guide AACR policy, overseeing its 58,000 members and various activities.”
Read further.
Source: Jean-Charles Soria/LinkedIn and Amgen Oncology/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023